Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of long-term tolerance to a specific antigen using anti-CD3 lipid nanoparticles following gene therapy.

Molecular therapy. Nucleic acids·2023
Same author

The Factory of Blood Production: Hematopoietic Stem Cells.

Methods in molecular biology (Clifton, N.J.)·2022
Same author

Hematopoietic Stem Cell Mobilization: Current Collection Approaches, Stem Cell Heterogeneity, and a Proposed New Method for Stem Cell Transplant Conditioning.

Stem cell reviews and reports·2021
Same author

A Single Radioprotective Dose of Prostaglandin E<sub>2</sub> Blocks Irradiation-Induced Apoptotic Signaling and Early Cycling of Hematopoietic Stem Cells.

Stem cell reports·2020
Same author

Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation.

Nature communications·2019
Same author

Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.

Cell·2017
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

8.1K

Gene Therapy for "Bubble Boy" Disease.

Jonathan Hoggatt1

  • 1Cancer Center and Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA 02129, USA.

Cell
|July 16, 2016
PubMed
Summary
This summary is machine-generated.

Gene therapy, Strimvelis, treats severe combined immunodeficiency (ADA-SCID) caused by adenosine deaminase deficiency. This therapy offers a vital option for patients lacking a bone marrow donor.

More Related Videos

Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.0K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.3K

Related Experiment Videos

Last Updated: Feb 24, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

8.1K
Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.0K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

7.3K

Area of Science:

  • Immunology
  • Genetics
  • Pharmacology

Background:

  • Adenosine deaminase (ADA) deficiency leads to toxic metabolite buildup, severely damaging the immune system.
  • This condition causes severe combined immunodeficiency (ADA-SCID), also known as "bubble boy" disease.

Purpose of the Study:

  • To evaluate the efficacy of Strimvelis gene therapy for ADA-SCID.
  • To provide an alternative treatment for ADA-SCID patients lacking a bone marrow donor.

Main Methods:

  • Utilizing gene therapy to correct ADA deficiency.
  • Administering Strimvelis to eligible ADA-SCID patients.

Main Results:

  • Strimvelis is approved by the European Medicines Agency for ADA-SCID treatment.
  • Gene therapy offers a viable treatment pathway for patients without matched bone marrow donors.

Conclusions:

  • Gene therapy with Strimvelis is a significant advancement in treating ADA-SCID.
  • This therapeutic approach addresses a critical unmet need for immune reconstitution in ADA-SCID patients.